Clinical Trial

Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 31, 2025 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to preoperatively predict DFS of patients with localised ccRCC using a deep learning prognostic model based on enhanced contrast CT images, validate it's predictive ability in multicentre data and compare it's predictive ability with traditional models.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-10-12; most recent amendment 2025-05-27.
Trial Details
NCT Number NCT06088134
Lead Sponsor Mingzhao Xiao
Conditions Clear Cell Renal Cell Carcinoma, Prognostic Cancer Model, Recurrent Renal Cell Cancer
Enrollment 800 participants
Start Date 2022-09-01
Primary Completion 2025-06-01 (estimated)
Study Completion 2025-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-31